Nexalin Technology, INC 8-K filings

NASDAQ

11 Apr 2024

NXL

8-K: Nexalin Technology Reports Positive Clinical Data and Advances Gen-3 HALO Clarity Device

Nexalin Technology announced positive clinical results for its neurostimulation device and progress on its new Gen-3 HALO Clarity & Virtual Clinic model.

NASDAQ

20 Mar 2024

NXL

Nexalin Technology, INC

8-K: Nexalin Technology Stockholders Approve Reverse Stock Split and Adjournment Authority at Special Meeting

Nexalin Technology stockholders voted to approve a reverse stock split and granted the board authority to determine the split ratio, as well as the ability to adjourn the special meeting if needed to gather more votes.